Darwin Global Management »

Belite Bio shares owned by Darwin Global Management

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Darwin Global Management from 13F filings

Historical chart of Darwin Global Management investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Darwin Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $487M 3.0M 160.82

More positions owned by Darwin Global Management

Insmed Com Par $.01 (INSM)
Belite Bio Sponsored Ads (BLTE)
Abivax Sa Sponsored Ads (ABVX)
Cidara Therapeutics Com New (CDTX)
Wave Life Sciences SHS (WVE)
Capricor Therapeutics Com New (CAPR)

View all positions for Darwin Global Management

Top funds holding Belite Bio

Darwin Global Management
RA Capital Management
Rtw Investments
Eventide Asset Management
Vestal Point Capital
Point72 Asset Management
Deerfield Management Company
Marshall Wace
UBS Group
MPM Oncology Impact Management
Holocene Advisors
Western Standard
Perceptive Advisors
Goldman Sachs Group
Soleus Capital Management

View all funds holding Belite Bio